BMC Cancer (Apr 2018)

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

  • Kim A. Brogden,
  • Deepak Parashar,
  • Andrea R. Hallier,
  • Terry Braun,
  • Fang Qian,
  • Naiyer A. Rizvi,
  • Aaron D. Bossler,
  • Mohammed M. Milhem,
  • Timothy A. Chan,
  • Taher Abbasi,
  • Shireen Vali

DOI
https://doi.org/10.1186/s12885-018-4200-5
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 1

Abstract

Read online

Abstract It has been highlighted that in the original manuscript [1] Table S3 ‘An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways’ was omitted and did not appear in the Additional files and that the Additional files were miss-numbered thereafter. This Correction shows the correct and incorrect Additional files. The original article has been updated.